Open AccessClearing the air
Author(s) -
John Damianos,
Dragana Skokovic-Sunjic,
David Armstrong
Publication year - 2021
Publication title -
@gijournal
Language(s) - English
Resource type - Journals
ISSN - 2768-1564
DOI - 10.52697/gijournal.v1i1.17
Subject(s) - irritable bowel syndrome , misinformation , confusion , probiotic , intensive care medicine , medicine , alternative medicine , psychology , political science , gastroenterology , pathology , biology , psychoanalysis , bacteria , law , genetics
There is tremendous interest in the use of probiotics to treat gastrointestinal diseases such as irritable bowel syndrome (IBS), but significant limitations to the research, lack of regulation of the probiotic market, and limited education surrounding probiotics have led to confusion and misinformation. In this article, we summarize our #TuesdayNightIBS discussion on the current state of affairs in probiotics research as it relates to IBS. We include a compilation of evidence based strains and combinations of strains specifically for IBS, and provide suggestions and resources that relate to the prescribing of probiotics for IBS.